{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T21:49:37Z","timestamp":1694987377210},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:00:00Z","timestamp":1349913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00059-012-3687-9","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T06:55:02Z","timestamp":1349765702000},"page":"859-868","source":"Crossref","is-referenced-by-count":2,"title":["Prophylactic implantable defibrillators in dilated cardiomyopathy"],"prefix":"10.1007","volume":"37","author":[{"given":"W.","family":"Grimm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,11]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","volume":"108","author":"Grimm","year":"2003","unstructured":"Grimm W, Christ M, Bach J et al (2003) Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy\u2014results of the Marburg Cardiomyopathy Study. Circulation 108:2883\u20132891","journal-title":"Circulation"},{"key":"3687_CR2","doi-asserted-by":"crossref","unstructured":"Grimm W, Christ M, Maisch B (2005) Long runs of nonsustained ventricular tachycardia predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. PACE 28(Suppl.1):207\u2013210","DOI":"10.1111\/j.1540-8159.2005.00035.x"},{"key":"3687_CR3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","volume":"105","author":"B\u00e4nsch","year":"2002","unstructured":"B\u00e4nsch D, Antz M, Boczor S et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. Circulation 105:1453\u20131458","journal-title":"Circulation"},{"key":"3687_CR4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","volume":"41","author":"Strickberger","year":"2003","unstructured":"Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomised trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. J Am Coll Cardiol 41:1707\u20131712","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(01)01822-8","volume":"39","author":"Grimm","year":"2002","unstructured":"Grimm W, Hoffmann J, M\u00fcller HH, Maisch B (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, non-sustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 39:780\u2013787","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(98)00306-4","volume":"32","author":"Grimm","year":"1998","unstructured":"Grimm W, Hoffmann J, Menz V et al (1998) Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 32:739\u2013745","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0002-8703(03)00148-0","volume":"146","author":"Grimm","year":"2003","unstructured":"Grimm W, Rudolph S, Christ M et al (2003) Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy. Am Heart J 146:372\u2013376","journal-title":"Am Heart J"},{"key":"3687_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","volume":"57","author":"Iles","year":"2011","unstructured":"Iles L, Pfluger H, Lefkovits L et al (2011) Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57:821\u2013828","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","volume":"12","author":"Theuns","year":"2010","unstructured":"Theuns DA, Smith T, Hunink MG et al (2010) Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischemic or non-ischemic heart disease: a systematic review and meta-analysis. Europace 12:1564\u20131570","journal-title":"Europace"},{"key":"3687_CR10","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","volume":"350","author":"Kadish","year":"2004","unstructured":"Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic cardiomyopathy. N Engl J Med 350:2151\u20132158","journal-title":"N Engl J Med"},{"key":"3687_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225\u2013237","journal-title":"N Engl J Med"},{"key":"3687_CR12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1388-9842(00)00150-1","volume":"3","author":"Cicoira","year":"2001","unstructured":"Cicoira M, Zanolla L, Latina L et al (2001) P. Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with classical clinical diagnosis of idiopathic dilated cardiomyopathy. Eur J Heart Failure 3:323\u2013330","journal-title":"Eur J Heart Failure"},{"key":"3687_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9149(99)00414-2","volume":"84","author":"Kawai","year":"1999","unstructured":"Kawai K, Takaoka H, Hata K et al (1999) Prevalence, predictors and prognosis of reversal of maladaptive remodelling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 84:671\u2013676","journal-title":"Am J Cardiol"},{"key":"3687_CR14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0735-1097(94)00543-Y","volume":"25","author":"Hall","year":"1995","unstructured":"Hall SA, Cigarroa CG, Marcoux L et al (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 25:1154\u20131161","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/hrt.2009.178061","volume":"96","author":"Verma","year":"2010","unstructured":"Verma A, Wulffhart Z, Lakkireddy D et al (2010) Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience. Heart 96:510\u2013515","journal-title":"Heart"},{"key":"3687_CR16","doi-asserted-by":"crossref","unstructured":"Zecchin M, Merlo M, Pivetta A et al (2012) How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \u201cSCD-HeFT criteria?\u201d Am J Cardiol 109:729\u2013735","DOI":"10.1016\/j.amjcard.2011.10.033"},{"key":"3687_CR17","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","volume":"103","author":"McNamara","year":"2001","unstructured":"McNamara DM, Holubkov R, Starling RC et al (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:2254\u20132259","journal-title":"Circulation"},{"key":"3687_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/oxfordjournals.eurheartj.a062314","volume":"8","author":"Pavan","year":"1987","unstructured":"Pavan D, Nicolosi GL, Lestuzzi C et al (1987) Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: an echocardiographic study. Eur Heart J 8:535\u2013540","journal-title":"Eur Heart J"},{"key":"3687_CR19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/europace\/eul108","volume":"8","author":"European","year":"2006","unstructured":"European Heart Rhythm Association, Heart Rhythm Society, Zipes DP et al (2006) American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice. Europace 8:746\u2013837","journal-title":"Europace"},{"key":"3687_CR20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539\u20131549","journal-title":"N Engl J Med"},{"key":"3687_CR21","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140\u20132150","journal-title":"N Engl J Med"},{"key":"3687_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1460-9592.2003.00007.x","volume":"26","author":"Grimm","year":"2003","unstructured":"Grimm W, Sharkova J, Funck R, Maisch B (2003) How many patients with dilated cardiomyopathy do potentially benefit from cardiac resynchronisation therapy using biventricular or left ventricular pacing? PACE 26:155\u2013157","journal-title":"PACE"},{"key":"3687_CR23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/europace\/euq362","volume":"12","author":"Dickstein","year":"2010","unstructured":"Dickstein K, Vardas PE, Auricchio A et al (2010) ESC Committee for Practice Guidelines. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:1526\u20131536","journal-title":"Europace"},{"key":"3687_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"Moss","year":"2009","unstructured":"Moss AJ, Hall WJ, Cannom DS et al. (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329\u20131338","journal-title":"N Engl J Med"},{"key":"3687_CR25","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"Tang","year":"2010","unstructured":"Tang AS, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385\u20132395","journal-title":"N Engl J Med"},{"key":"3687_CR26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/CIRCULATIONAHA.112.097709","volume":"126","author":"Gold","year":"2012","unstructured":"Gold MR, Th\u00e9bault C, Linde C et al (2012) The effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study. Circulation 126:822\u2013829","journal-title":"Circulation"},{"key":"3687_CR27","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","volume":"59","author":"Hsu","year":"2012","unstructured":"Hsu JC, Solomon SD, Bourgoun M, et al (2012) Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 59:2366\u20132373","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/europace\/eup035","volume":"11","author":"Castellant","year":"2009","unstructured":"Castellant P, Fatemi M, Orhan E et al (2009) Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. Europace 11:350\u2013355","journal-title":"Europace"},{"key":"3687_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/europace\/eup038","volume":"11","author":"Ant\u00f3nio","year":"2009","unstructured":"Ant\u00f3nio N, Teixeira R, Coelho L et al (2009) Identification of \u2018super-responders\u2019 to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry. Europace 11:343\u2013349","journal-title":"Europace"},{"key":"3687_CR30","unstructured":"Grimm W, Waldhans S, ElFarra H, Moosdorf M (2010) Complications of implantable cardioverter defibrillator therapy in 805 consecutive patients. Europace 12(Suppl.1):i100"},{"key":"3687_CR31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2011.04.039","volume":"58","author":"Dewland","year":"2011","unstructured":"Dewland TA, Pellegrini CN, Wang Y et al (2011) Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 58:1007\u20131013","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2011.06.007","volume":"58","author":"Rees","year":"2011","unstructured":"Rees JB van, Bie MK de, Thijssen J et al (2011) Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 58:995\u20131000","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","volume":"57","author":"Rees","year":"2011","unstructured":"Rees JB van, Borleffs CJ, Bie MK de et al (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57:556\u2013562","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR34","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1161\/CIRCULATIONAHA.104.526673","volume":"111","author":"Sweeney","year":"2005","unstructured":"Sweeney MO, Wathen MS, Volosin K et al (2005) Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 111:2898\u20132905","journal-title":"Circulation"},{"key":"3687_CR35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","volume":"52","author":"Wilkoff","year":"2008","unstructured":"Wilkoff BL, Williamson BD, Stern RS et al (2008) Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 52:541\u2013550","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1540-8159.2006.00431.x","volume":"29","author":"Grimm","year":"2006","unstructured":"Grimm W, Plachta E, Maisch B (2006) Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. PACE 29:759\u2013764","journal-title":"PACE"},{"key":"3687_CR37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.hrthm.2012.02.027","volume":"9","author":"Sweeney","year":"2012","unstructured":"Sweeney MO, Sakaguchi S, Simons G et al (2012) Response to the center for medicare & medicaid services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: data from the OMNI study. Heart Rhythm 9:1058\u20131066","journal-title":"Heart Rhythm"},{"key":"3687_CR38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1540-8159.2009.02566.x","volume":"33","author":"Verma","year":"2010","unstructured":"Verma A, Sarak B, Kaplan AJ et al (2010) Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol 33:320\u2013329","journal-title":"Pacing Clin Electrophysiol"},{"key":"3687_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2010.1915","volume":"305","author":"Al-Khatib","year":"2011","unstructured":"Al-Khatib SM, Hellkamp A, Curtis J et al (2011) Non-evidence-based ICD implantations in the United States. JAMA 305:43\u201349","journal-title":"JAMA"},{"key":"3687_CR40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/clc.20860","volume":"33","author":"Richard","year":"2010","unstructured":"Richard Conti C (2010) Automatic external defibrillator, life vest defibrillator, or both? Clin Cardiol 33:722\u2013723","journal-title":"Clin Cardiol"},{"key":"3687_CR41","doi-asserted-by":"crossref","first-page":"A278","DOI":"10.1161\/CIRCULATIONAHA.111.040170","volume":"124","author":"Mossesso","year":"2011","unstructured":"Mossesso VN, Li J, Landsittel D, Ganz LI (2011) Successful conversion of ventricular tachyarrhythmias by wearable defibrillator. Circulation 124:A278 (Abstract)","journal-title":"Circulation"},{"key":"3687_CR42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/CIRCULATIONAHA.111.023887","volume":"126","author":"Sweeney","year":"2012","unstructured":"Sweeney MO (2012) The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators. Circulation 126:369\u2013377","journal-title":"Circulation"},{"key":"3687_CR43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.hrthm.2005.01.015","volume":"2","author":"Russo","year":"2005","unstructured":"Russo AM, Sauer W, Gerstenfeld EP et al (2005) Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2:456\u2013461","journal-title":"Heart Rhythm"},{"key":"3687_CR44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacc.2008.04.051","volume":"52","author":"Blatt","year":"2008","unstructured":"Blatt JA, Poole JE, Johnson GW et al (2008) No benefit from defibrillation threshold testing in the SCD-HeFT. J Am Coll Cardiol 52:551\u2013556","journal-title":"J Am Coll Cardiol"},{"key":"3687_CR45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCULATIONAHA.111.053744","volume":"125","author":"Birnie","year":"2012","unstructured":"Birnie DH, Parkash R, Exner DV et al (2012) Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation 125:1217\u20131225","journal-title":"Circulation"},{"key":"3687_CR46","doi-asserted-by":"crossref","unstructured":"Shen S, Bhave P, Giedrimas E et al (2012) Prevalence and predictors of cable extrusion and loss of electrical integrity with the riata defibrillator lead. J Cardiovasc Electrophysiol [Epub ahead of print]","DOI":"10.1111\/j.1540-8167.2012.02378.x"},{"key":"3687_CR47","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.hrthm.2008.09.020","volume":"5","author":"Gould","year":"2008","unstructured":"Gould PA, Gula LJ, Champagne J et al (2008) Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm 5:1675\u20131681","journal-title":"Heart Rhythm"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3687-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-012-3687-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3687-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:24:10Z","timestamp":1562250250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-012-3687-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1007\/s00059-012-3687-9","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,11]]}}}